Medicine and Dentistry
Arm
100%
Best Corrected Visual Acuity
35%
Central Retinal Vein Occlusion
100%
Combination Therapy
7%
Cost-Effectiveness Analysis
28%
Feedback System
7%
Health Care
7%
Health Care Cost
21%
Injection
14%
Intention-to-Treat Analysis
21%
Intravitreal Administration
7%
Macular Edema
100%
Noninferiority Trial
7%
Ophthalmology
7%
Patient
21%
Post-Hoc Analysis
21%
Quality Adjusted Life Year
14%
Randomized Controlled Trial
100%
Therapeutic Procedure
28%
Vision
21%
Visual Acuity
21%
Visual Impairment
7%
Neuroscience
Bevacizumab
100%
Central Retinal Vein
100%
Intention
21%
Ophthalmology
7%
Ranibizumab
100%
Retinal Vein Occlusion
100%
Food Science
Bioactive Compound
40%
Nutrient
100%
Plum
100%
Real-Time Polymerase Chain Reaction
14%
Short Chain Fatty Acid
42%
Starch
20%